Pharmaceutical
October 29, 2008
A report issued from IMS Health says that U.S. sales of pharmaceuticals will grow at the slowest rate on record this year, as the weakening economy compounds other factors
Read More
October 20, 2008
The Associated Press reports that Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra. The Pfizer agreement will
Read More
October 15, 2008
The Associated Press reports that Synta Pharmaceuticals Inc. will receive a $25 million payment from GlaxoSmithKline PLC after reaching milestones under a development agreement for the cancer drug elesclomol. The
Read More
October 13, 2008
The state of Alabama has settled Medicaid drug pricing lawsuits it filed against prescription drug manufacturer Bristol-Myers Squibb and four other companies, according to the Associated Press. Bristol-Myers Squibb is
Read More
October 13, 2008
The Associated Press reports that Rohm and Haas Co. has resumed full supply for some products at two Texas plants affected by Hurricane Ike in September. A plant at Deer
Read More
October 8, 2008
Reuters has reported that documents submitted in a U.S. lawsuit against Pfizer Inc. claim the company tried to internally suppress medical studies that did not support the use of its
Read More
October 6, 2008
According to the Associated Press, Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that will expand Lilly''s
Read More
September 22, 2008
Biotechnology company Molecular Insight Pharmaceuticals Inc. has added four new directors to its board, including employees of GlaxoSmithKline PLC and Novartis AG, the Associated Press reported. The company named David
Read More
September 17, 2008
The Associated Press reports that Biotechnology company Cytokinetics Inc. has announced it will slash its work force by 29 percent and end research activities on potential cancer treatments as part
Read More
September 12, 2008
Drug developer King Pharmaceuticals Inc. launched its tender offer for rival Alpharma Inc., taking its offer directly to shareholders after raising its bid 12 percent to $1.6 billion, as reported
Read More